VANCOUVER, Dec. 8, 2016 /CNW/ - Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) ("Reliq" or the "Company"), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has opened an office in the UK to support Reliq's expansion into the European market.
"We are very pleased to be opening an office in London, England in response to strong interest from the UK market," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Reliq recently launched a pilot with the NHS England at Imperial College Hospital in London to validate the use of our remote patient monitoring and care collaboration solution for patients with chronic conditions. Opening an office in the UK allows us to better support this pilot and acquire new customers in the UK and the rest of Europe. Reliq's virtual care platform was designed to reduce readmissions and improve health outcomes for patients with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes. Our technology allows patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction."
Currently there are over 15 million people in England living with at least one long-term health condition. In addition to the impact on people's lives, long-term condition management accounts for half of all General Practitioner appointments and 70% of hospital bed days in the UK. Reliq Health's proprietary hardware and software supports patients and their caregivers in the home, providing remote vitals monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored patient education and secure communication with the entire care team.
Reliq's UK office is located at Impact Hub Westminster, 1st Floor New Zealand House, 80 Haymarket, London SW1Y 4TE. The entire funding for the UK office was provided by the UK Department of International Trade's Global Entrepreneur Programme, which supports entrepreneurs and early stage technology businesses that wish to locate in the UK.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE Reliq Health Technologies Inc.
For further information: Renmark Financial Communications Inc., Laura Welsh: firstname.lastname@example.org, Tel: (416) 644-2020 or (514) 939-3989, www.renmarkfinancial.com; or CORE Capital Partners at 604-566-9233 or email@example.com